Medicon Hellas SA
ATHEX:MEDIC
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| GR |
M
|
Medicon Hellas SA
ATHEX:MEDIC
|
11.6m EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD |
Loading...
|
Market Distribution
| Min | -10 460.4% |
| 30th Percentile | 1.9% |
| Median | 8.6% |
| 70th Percentile | 20.4% |
| Max | 3 030.4% |
Other Profitability Ratios
Medicon Hellas SA
Glance View
Medicon Hellas SA engages in the business of medical technology. The company is headquartered in Athina, Attiki. The company went IPO on 2001-07-11. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Medicon Hellas SA is 10.1%, which is above its 3-year median of 7.7%.
Over the last 3 years, Medicon Hellas SA’s Net Margin has decreased from 12.6% to 10.1%. During this period, it reached a low of 4.2% on Jun 30, 2024 and a high of 12.6% on May 30, 2022.
